These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3755019)

  • 1. [Phase I study of bestrabucil (KM 2210)].
    Kamei H; Takenaka K; Goto T; Suga S; Fugiwara A; Nakao I; Agatsuma T; Fujita K; Isurugi K; Kubota T
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2208-15. PubMed ID: 3755019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Early phase II trial of bestrabucil in hematological malignancies].
    Nagura E; Ohno R; Yamada K; Akao Y; Naito K; Nishikawa M; Tanaka H; Shirakawa S; Ono Y; Ezaki K
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2216-22. PubMed ID: 3459398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bestrabacil: a possible target-oriented anticancer agent].
    Ohsawa N; Yamazaki Z; Wagatsuma T; Isurugi K
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2115-24. PubMed ID: 6548354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical trial of bestrabucil (KM 2210) on hematopoietic malignancies].
    Nishikawa M; Uemura Y; Matsuoka N; Ohno T; Katayama N; Tomeoku M; Kobayashi T; Kita K; Tanaka H; Minami N
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2155-9. PubMed ID: 3521494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic results in recurrent breast cancer with the use of Bestrabucil (KM2210)].
    Ueda T; Sakai K; Morimoto K; Nakatani S
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3285-9. PubMed ID: 3688892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II multi-institutional study of estra-1,3,5(10)-triene-3,17 beta-diol, 3-benzoate, 17[[4-[4-[bis(2-chloroethyl)amino]phenyl]-1- oxobutoxy]acetate] (KM2210), a novel antitumor agent, for advanced and recurrent breast carcinoma.
    Kubota T; Abe O; Izuo M; Watanabe H; Enomoto K; Ohsawa N; Kuno K
    Anticancer Res; 1993; 13(6B):2361-5. PubMed ID: 8135468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A phase I study of 4'-epi-adriamycin, a new anthracycline anticancer agent].
    Kimura K; Wakui A; Saito T; Tominaga T; Niitani H; Fujimoto T; Masaoka T; Toki H; Tamura K
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2414-9. PubMed ID: 6594078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical effects of bestrabucil (KM2210) in bladder cancer].
    Nasu Y; Saegusa M; Ochi J; Hara M; Akagi T; Obama T; Yoshimoto J; Matsumura Y; Ohmori H; Tsushima T
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3155-6. PubMed ID: 3674900
    [No Abstract]   [Full Text] [Related]  

  • 10. [Phase I clinical study of 21-consecutive-day oral administration of etoposide].
    Noda K; Fukuoka M; Komatsu H; Hayashihara K; Ariyoshi Y; Tanaka K; Nakajima H; Terashima Y; Nagao K; Furuse K
    Gan To Kagaku Ryoho; 1994 Aug; 21(10):1633-9. PubMed ID: 8060139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical trial of bestrabucil (KM 2210) in hematopoietic malignancies].
    Naito K; Kubo K; Akao Y; Hiraiwa A; Naoe T; Yamada K
    Gan No Rinsho; 1986 Sep; 32(11):1443-50. PubMed ID: 2877106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical phase I study of TNP-351. The TNP-351 Research Committee].
    Taguchi T; Niitani H; Furue H; Tsukagoshi S; Kanamaru R; Hasegawa K; Akazawa S; Yoneda S; Tominaga T; Sasaki T
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):259-71. PubMed ID: 7857102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of carcinoma in the lower abdomen treated successfully with oral administration of bestrabucil].
    Tsujitani S; Baba H; Korenaga D; Haraguchi M; Hiramoto Y; Okamura T; Sugimachi K
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2960-3. PubMed ID: 3662547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I clinical trial: pharmacokinetics of a novel anthracycline, DA-125 and metabolites. Single dose study.
    Roh JK; Rha SY; Lee CI; Lee KH; Lee JJ; Shim HJ; Lee SD; Kim WB; Yang J; Kim SH; Lee MG
    Int J Clin Pharmacol Ther; 1998 Jun; 36(6):312-9. PubMed ID: 9660038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A new anti-cancer agent, bestrabucil (KM 2210): I. Concentration in the serum and tissue in urogenital tumors].
    Nasu Y; Saegusa M; Hara M; Ochi J; Akagi T; Obama T; Tsushima T; Yoshimoto J; Ozaki Y; Matsumura Y
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1116-21. PubMed ID: 3566306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I trial of pentamethylmelamine in patients with previously treated malignancies.
    Van Echo DA; Chiuten DF; Whitacre M; Aisner J; Lichtenfeld JL; Wiernik PH
    Cancer Treat Rep; 1980; 64(12):1335-9. PubMed ID: 6781747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical application of KM 2210 (estradiol-chlorambucil) in patients with advanced prostatic carcinoma].
    Isurugi K
    Gan No Rinsho; 1984 Jun; 30(7):810-8. PubMed ID: 6547748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination chemotherapy with nedaplatin, bleomycin and ifosfamide for advanced cervical cancer of the uterus--a preliminary study for phase III clinical study].
    Noda K; Hirabayashi K; Terashima Y; Ozaki M; Yakushiji M; Hatae M; Kanazawa K
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1285-93. PubMed ID: 9279348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phase I study of raltitrexed (ZD-1694)].
    Horikoshi N; Aiba K; Fukuoka M; Akazawa S; Sakata Y; Furuse K; Kanamaru R; Kudoh S; Konishi T; Kurihara M; Niitani H; Furue H; Tsukagoshi S; Taguchi T; Yoshida S; Ota K; Kotake T; Wakui A
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2075-84. PubMed ID: 9838910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phase I clinical study of TT-62. Research group of TT-62].
    Taguchi T; Furue H; Niitani H; Ohta K; Tsukagoshi S; Wakui A; Hasegawa K; Nakao I; Ohashi Y; Tominaga T
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):241-6. PubMed ID: 8434962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.